Compare BDSX & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | ATOM |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.2M | 157.7M |
| IPO Year | 2020 | 2016 |
| Metric | BDSX | ATOM |
|---|---|---|
| Price | $28.11 | $3.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.50 | N/A |
| AVG Volume (30 Days) | 112.9K | ★ 428.0K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.41 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,499,000.00 | $62,000.00 |
| Revenue This Year | $25.26 | $527.69 |
| Revenue Next Year | $19.15 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $5.26 | $1.89 |
| 52 Week High | $31.31 | $12.37 |
| Indicator | BDSX | ATOM |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 29.15 |
| Support Level | $19.26 | $3.46 |
| Resistance Level | $31.31 | $5.87 |
| Average True Range (ATR) | 1.89 | 0.21 |
| MACD | -0.11 | 0.03 |
| Stochastic Oscillator | 50.14 | 8.33 |
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used in the semiconductor industry. The company's silicon technology can be used for applications like Analog, DRAM, logic, processors, and SRAM. Geographically, it generates maximum revenue from North America.